Anzahl der Publikationen: 5
Zeitschriftenartikel
Römer, Tristan; Franzen, Sabrina; Kravets, Hanna; Farrag, Ahmed; Makowska, Anna; Christiansen, Hans; Eble, Michael J.; Timmermann, Beate; Staatz, Gundula; Mottaghy, Felix M.; Bührlen, Martina; Hagenah, Ulrich; Puzik, Alexander; Driever, Pablo Hernaiz; Greiner, Jeanette; Jorch, Norbert; Tippelt, Stephan; Schneider, Dominik T.; Kropshofer, Gabriele; Overbeck, Tobias R.; Christiansen, Holger; Brozou, Triantafyllia; Escherich, Gabriele; Becker, Martina; Friesenbichler, Waltraud; Feuchtinger, Tobias; Puppe, Wolfram; Heussen, Nicole; Hilgers, Ralf D. und Kontny, Udo
(2022):
Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort.
In: Cancers, Bd. 14, Nr. 5, 1261
Berthold, Frank; Ernst, Angela; Ackermann, Sandra; Bartenhagen, Christoph; Christiansen, Holger; Hero, Barbara; Rosswog, Carolina; Schweinitz, Dietrich von; Klingebiel, Thomas; Schmid, Irene; Simon, Thorsten und Fischer, Matthias
(2021):
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification.
In: Cancers, Bd. 13, Nr. 17, 4360
Berthold, Frank; Rosswog, Carolina; Christiansen, Holger; Fruhwald, Michael; Hemstedt, Nadine; Klingebiel, Thomas; Frohlich, Birgit; Schilling, Freimut H.; Schmid, Irene; Simon, Thorsten; Hero, Barbara; Fischer, Matthias und Ernst, Angela
(2021):
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification.
In: Pediatric Blood & Cancer, Bd. 68, Nr. 8, e29038
Schramm, Franziska; zur Stadt, Udo; Zimmermann, Martin; Jorch, Norbert; Pekrun, Arnulf; Borkhardt, Arndt; Imschweiler, Thomas; Christiansen, Holger; Faber, Jörg; Schmid, Irene; Feuchtinger, Tobias; Beron, Gerhard; den Boer, Monique L.; Pieters, Rob; Horstmann, Martin A.; Janka-Schaub, Gritta E. und Escherich, Gabriele
(2019):
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity.
In: Blood Advances, Bd. 3, Nr. 22: S. 3688-3699
Schramm, Franziska; Zimmermann, Martin; Jorch, Norbert; Pekrun, Arnulf; Borkhardt, Arndt; Imschweiler, Thomas; Christiansen, Holger; Faber, Jörg; Feuchtinger, Tobias; Schmid, Irene; Beron, Gerhard; Horstmann, Martin A. und Escherich, Gabriele
(2019):
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09.
In: Leukemia & Lymphoma, Bd. 60, Nr. 1: S. 60-68
Diese Liste wurde am
Sat Dec 21 22:37:52 2024 CET
erstellt.